We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


EKF’s New Altair™240 Clinical Chemistry Analyser Revealed To UK Audience at IBMS 2015

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "EKF’s New Altair™240 Clinical Chemistry Analyser Revealed To UK Audience at IBMS 2015"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

EKF Diagnostics announces the UK launch of the Altair™ 240 clinical chemistry analyser at the Institute of Biomedical Science Congress 2015 in Birmingham, UK, 28-30 September. This new bench-top platform represents EKF Diagnostics’ first fully integrated chemistry system designed for the global market. Also on Stand 812, EKF will highlight the latest additions to its range of Stanbio liquid-stable, LiquiColor® and Liqui-UV® clinical chemistry reagents, including an assay for Procalcitonin - an important adjunct marker in the diagnosis of sepsis.


The new Altair™ 240 clinical chemistry analyser fulfills a need for a fully automated and cost-effective, bench-top platform supported by the reliable and respected Stanbio Chemistry reagent menu. Built on 54 years of clinical chemistry expertise, the fully automated system with LIS bi-directional connectivity is easy to use, as either a main or back-up analyser, and is capable of performing up to 480 tests/hour*. In addition to being supported by EKF’s broad menu of Stanbio ready-to-use, bar coded, liquid reagents for routine and special chemistries, the Altair™ 240 also provides the flexibility to configure open channel applications for many esoteric assays.

Also on Stand 812, the Stanbio Chemistry Procalcitonin (PCT) LiquiColor® Assay is a new test enabling the quantitative determination of PCT in serum samples, EDTA or lithium heparin plasma samples by latex enhanced immunoturbidimetric methodology. PCT is a marker for bacterial infection and sepsis and has been recognized as an important adjunct marker in the diagnosis of sepsis**.

The new Stanbio Chemistry Procalcitonin (PCT) LiquiColor® Assay is fast, accurate and convenient. The test provides a precise result, which correlates well with established methodology, within 10 minutes and requires just 20 µL of sample. The reagents may be used on almost any liquid-based chemistry analyser with open-channel capability. In addition, the reagent kit, calibrator and control sets are all available separately. 

Other assays from the Stanbio Chemistry range can also be seen at Stand 812 including the B-Hydroxybutyrate (B-HB) LiquiColor® Assay for ketosis testing and the Glycated Serum Protein (GSP) LiquiColor® Assay, a two-three week indicator of average blood glucose. In addition, EKF Diagnostics’ Quo-Lab™ and Quo-Test™ – devices for the accurate measurement of HbA1c – will also be showcased at IBMS, as will the Hemo Control haemoglobin analyser. 

*Double arm functionality yields up to 480 tests per hour


1. Müller B, et al., Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001; 86(1):396-404.

2. Meisner M. Procalcitonin (PCT) – A new, innovative infection parameter. Biochemical and clinical aspects. Thieme; Stuttgart, New York, 2000; ISBN 3-13-105503-0.

3. Christ-Crain M, et al., Procalcitonin in bacterial infections – hype, hope or more or less? Swiss Med Wkly 2005; 135: 451-60.